Australia's Next Science jumps on appointing distributors for wound gel

Next Science

19/05/2022 04:30

** Shares of medical technologies co Next Science  NXS.AX 
rise as much as 8.5% to A$0.89, their best intraday session
since Jan. 31
    ** Says it signed a distribution agreement with Oraderm
Pharmaceutical for the sale of its antimicrobial wound gel
BlastX  urn:newsml:reuters.com:*:nASX69SbxT
    ** Agreement for distribution in Australia and New Zealand
for five years, which automatically extends to another three
years 
    ** Stock down 34.1% YTD, as of last close 

 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))